People in the News: DermTech Bolsters Sales Team; Diomics Names Kindt as CSO | GenomeWeb

DermTech International said this week that it has added three members to its commercialization team: Art Wampole will lead the company's sales efforts, Annie Bell its marketing strategy, and Mildred Romero its reimbursement implementation.

Wampole was previously vice president of sales at Dermpath Diagnostics, a division of Ameripath, now part of Quest Diagnostics.

Bell held senior management positions in sales and marketing for Ameripath, and was the general manager of Dermpath Diagnostics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.